Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab vs Hemodilution in Early-onset CRVO
NCT01448018Phase 4Completed
- Sponsor
- Centre Hospitalier Intercommunal de Créteil
- Start
- Jan 2010
- Primary completion
- Jun 2013
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in central retinal vein occlusion (CRVO), sponsored by Centre Hospitalier Intercommunal de Créteil. Started Jan 2010; status: completed.
02
Drugs
ranibizumab
03
Conditions
central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on NCT01448018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01448018.